Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Balance Sheet: Assets 
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Johnson & Johnson, consolidated balance sheet: assets (quarterly data)

US$ in millions

Microsoft Excel
Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents 19,980 24,878 25,473 21,859 19,728 21,183 19,170 14,127 11,355 10,983 10,463 14,487 17,604 14,332 12,671 13,985 18,965 11,174 15,530 17,305 16,249 14,376 14,734
Restricted cash 7,695
Marketable securities 317 597 745 1,068 3,783 7,322 5,443 9,392 22,724 21,585 19,925 17,121 13,397 10,974 11,948 11,200 11,816 7,961 2,494 1,982 1,696 902 602
Accounts receivable, trade, less allowances 16,174 15,794 14,946 14,873 14,798 16,777 16,350 16,160 15,890 16,139 15,594 15,283 14,911 14,871 14,938 13,576 14,579 14,645 14,874 14,481 14,801 14,653 14,115
Inventories 12,603 12,169 11,383 11,181 11,198 12,888 12,809 12,483 11,675 11,437 10,990 10,387 10,387 10,100 9,952 9,344 9,599 9,424 8,868 9,020 9,173 9,263 9,086
Prepaid expenses and other 4,175 4,379 4,455 4,514 4,196 2,397 2,921 3,132 3,592 3,703 3,452 3,701 3,590 3,492 3,024 3,132 2,528 2,588 2,358 2,392 2,220 2,411 2,599
Assets held for sale 91 100 102 94 194 194 851
Current assets 53,249 57,817 57,002 53,495 53,703 60,567 64,388 55,294 65,236 63,847 60,424 60,979 59,889 53,769 52,533 51,237 57,578 45,892 44,226 45,274 44,333 41,799 41,987
Property, plant and equipment at cost 49,274 48,035 47,585 47,776 45,626 51,218 50,367 49,253 46,681 47,144 47,702 47,679 47,347 47,201 46,430 46,804 45,162 44,056 43,247 43,332 42,625 42,905 42,262
Accumulated depreciation (28,795) (28,287) (27,953) (27,878) (26,805) (30,642) (30,193) (29,450) (28,529) (28,790) (29,001) (28,717) (28,869) (28,569) (28,063) (28,038) (27,307) (26,458) (25,846) (25,674) (25,577) (25,657) (25,262)
Property, plant and equipment, net 20,479 19,748 19,632 19,898 18,821 20,576 20,174 19,803 18,152 18,354 18,701 18,962 18,478 18,632 18,367 18,766 17,855 17,598 17,401 17,658 17,048 17,248 17,000
Intangible assets, net 39,490 39,725 34,286 34,175 35,021 46,246 47,448 48,325 40,336 42,408 44,420 46,392 47,776 50,244 51,110 53,402 47,006 47,413 47,338 47,643 47,846 49,332 46,898
Goodwill 44,799 44,250 36,616 36,558 36,124 45,440 45,575 45,231 33,383 34,166 34,935 35,246 35,569 35,819 35,688 36,393 34,307 33,890 33,471 33,639 33,291 33,661 31,450
Deferred taxes on income 9,349 9,004 10,305 9,279 9,259 8,779 8,817 9,123 9,392 9,514 9,936 10,223 10,646 10,804 8,321 8,534 7,816 7,805 7,539 7,819 7,696 7,647 7,533
Other assets 10,921 10,544 14,125 14,153 13,133 10,078 9,567 9,602 8,625 9,435 9,939 10,216 6,870 7,172 6,538 6,562 6,131 5,782 5,042 5,695 5,307 5,430 5,159
Non-current assets 125,038 123,271 114,964 114,063 112,358 131,119 131,581 132,084 109,888 113,877 117,931 121,039 119,339 122,671 120,024 123,657 113,115 112,488 110,791 112,454 111,188 113,318 108,040
Total assets 178,287 181,088 171,966 167,558 166,061 191,686 195,969 187,378 175,124 177,724 178,355 182,018 179,228 176,440 172,557 174,894 170,693 158,380 155,017 157,728 155,521 155,117 150,027

Based on: 10-Q (reporting date: 2024-09-29), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-27), 10-Q (reporting date: 2020-06-28), 10-Q (reporting date: 2020-03-29), 10-K (reporting date: 2019-12-29), 10-Q (reporting date: 2019-09-29), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Johnson & Johnson current assets increased from Q1 2024 to Q2 2024 but then decreased significantly from Q2 2024 to Q3 2024.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Johnson & Johnson property, plant and equipment, net increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Johnson & Johnson non-current assets increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Johnson & Johnson total assets increased from Q1 2024 to Q2 2024 but then slightly decreased from Q2 2024 to Q3 2024.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Johnson & Johnson cash and cash equivalents decreased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Marketable securities Amount of investment in marketable security, classified as current. Johnson & Johnson marketable securities decreased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Accounts receivable, trade, less allowances Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Johnson & Johnson accounts receivable, trade, less allowances increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Johnson & Johnson inventories increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.